Bioventus
BVS
BVS
98 hedge funds and large institutions have $451M invested in Bioventus in 2021 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 41 increasing their positions, 9 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
28% more capital invested
Capital invested by funds: $352M → $451M (+$99.7M)
8.07% less ownership
Funds ownership: 60.51% → 52.45% (-8.1%)
90% less call options, than puts
Call options by funds: $94K | Put options by funds: $958K
Holders
98
Holding in Top 10
4
Calls
$94K
Puts
$958K
Top Buyers
| 1 | +$31.1M | |
| 2 | +$25.9M | |
| 3 | +$22.9M | |
| 4 |
BlackRock
New York
|
+$15.7M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.9M |
Top Sellers
| 1 | -$37.9M | |
| 2 | -$16.4M | |
| 3 | -$5.5M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$2.39M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$2.3M |